Skip to main content
Oksana (Olyva) Hamidi, DO, Endocrinology, Dallas, TX

Oksana(Olyva)HamidiDO

Endocrinology Dallas, TX

Adrenal Disease, Pituitary Disorders & Neuroendocrinology

Assistant Professor

Dr. Hamidi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hamidi's full profile

Already have an account?

  • Office

    5323 Harry Hines Boulevard
    Dallas, TX 75390
    Phone+1 214-645-2800
    Fax+1 214-645-2808

Summary

  • Dr. Oksana Hamidi is an endocrinologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. She received her medical degree from Chicago College of Osteopathic Medicine and has been in practice 5 years. She specializes in adrenal disease, diabetes, lipid metabolism, and pituitary disorders & neuroendocrinology and is experienced in pituitary disease, adrenal disease, and neuroendocrinology.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2018
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 2012 - 2015
  • Chicago College of Osteopathic Medicine at Midwestern University
    Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2012

Certifications & Licensure

  • TX State Medical License
    TX State License 2018 - 2026
  • MN State Medical License
    MN State License 2015 - 2018
  • IL State Medical License
    IL State License 2012 - 2015
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

Press Mentions

  • Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
    Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024May 10th, 2024
  • CAH Treatment 'Struggle' Points to Unmet Need
    CAH Treatment 'Struggle' Points to Unmet NeedMay 16th, 2024
  • UTSW Research: Female Sex Hormones, Adrenal Hyperplasia, and More
    UTSW Research: Female Sex Hormones, Adrenal Hyperplasia, and MoreJuly 3rd, 2024

Professional Memberships